As Taiwan continues to advance integrated neurological care and smart medical technologies[1], Zinexts is expanding its molecular diagnostics portfolio into one of today’s most challenging areas of healthcare: neurodegenerative diseases. Zinexts proudly supports Taiwan’s development of advanced neurology care through its fully automated sample-to-result solution, NeXgen™ 16HP, and
